Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.3 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |
mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.3 | 0.4 |